Clinical and molecular cytogenetic studies in seven patients with myeloid diseases characterized by i(20q-)

被引:37
|
作者
Li, TY [1 ]
Xue, YQ [1 ]
Wu, YF [1 ]
Pan, JL [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Haematol, Suzhou 215006, Peoples R China
关键词
myeloid disease; isochromosome; deletion of 20q; fluorescence in situ hybridization; prognosis;
D O I
10.1111/j.1365-2141.2004.04921.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report on seven patients with myeloid diseases characterized by i(20q-) anomaly. Four patients were male and three were female, their median age was 57 years. The diagnosis at presentation was myelodysplastic syndrome in six patients, acute myeloid leukaemia in one patient. Four died but three survived and remain anaemic. The survivals were 6 months for patient 1, 7 months for patient 2, 17 d for patient 4 and 28 d for patient 5. Chromosome specimens were prepared by direct and/or short-term culture of bone marrow cells. Karyotype analysis was performed by R- and G-banding technique, which showed that one of the normal chromosomes 20 was substituted by one or two small metacentric chromosomes in all seven patients. The karyotype was ider(20)(q10)del(20)(q11q13), i.e. i(20q-) in six patients by dual-colour fluorescence in situ hybridization assay using two probes (a subtelomeric probe for 20q and an unique probe for 20q12). As far as we know, this anomaly has not been reported previously. Thus, we consider that i(20q-) is a novel and rare recurrent chromosomal abnormality that is specifically associated with myeloid diseases and may indicate a poor prognosis.
引用
收藏
页码:337 / 342
页数:6
相关论文
共 6 条
  • [1] Clinical and molecular cytogenetic studies in ten patients with hematological malignancies characterized by t(20;21)(q11;q11) resulted from del(20q)
    Wu, Chunxiao
    Zhang, Jun
    Bai, Shuxiao
    Yao, Jianxin
    Qiu, Huiying
    Xue, Yongquan
    Chen, Suning
    Wu, Yafang
    Shen, Juan
    Pan, Jinlan
    Cancer Genetics, 2016, 209 (10) : 456 - 462
  • [2] Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide
    Sugimoto, Yuka
    Sekeres, Mikkael A.
    Makishima, Hideki
    Traina, Fabiola
    Visconte, Valeria
    Jankowska, Anna
    Jerez, Andres
    Szpurka, Hadrian
    O'Keefe, Christine L.
    Guinta, Kathryn
    Afable, Manuel
    Tiu, Ramon
    McGraw, Kathy L.
    List, Alan F.
    Maciejewski, Jaroslaw
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
  • [3] Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide
    Yuka Sugimoto
    Mikkael A Sekeres
    Hideki Makishima
    Fabiola Traina
    Valeria Visconte
    Anna Jankowska
    Andres Jerez
    Hadrian Szpurka
    Christine L O'Keefe
    Kathryn Guinta
    Manuel Afable
    Ramon Tiu
    Kathy L McGraw
    Alan F List
    Jaroslaw Maciejewski
    Journal of Hematology & Oncology, 5
  • [4] Refining the Diagnosis and Prognostic Categorization of Acute Myeloid Leukemia Patients with an Integrated Use of Cytogenetic and Molecular Studies
    Costa, Dolors
    Vidal, Anna
    Carrio, Ana
    Munoz, Concha
    Arias, Amparo
    Gomez, Candida
    Berneaga, Daniela
    Colomer, Dolors
    Rozman, Maria
    Pratcorona, Marta
    Torrebadell, Montserrat
    Diaz-Beya, Marina
    Esteve, Jordi
    Campo, Elias
    ACTA HAEMATOLOGICA, 2013, 129 (02) : 65 - 71
  • [5] Clinical and molecular cytogenetic studies in three infertile patients with mosaic rearranged Y chromosomes
    Bettio, D
    Venci, A
    Rizzi, N
    Negri, L
    Setti, PL
    HUMAN REPRODUCTION, 2006, 21 (04) : 972 - 975
  • [6] Conventional and molecular cytogenetic studies to characterize 32 complex variant Philadelphia translocations in patients with chronic myeloid leukemia
    Costa, Dolors
    Grau, Javier
    Espinet, Blanca
    Arias, Amparo
    Gomez, Candida
    Lopez-Guerra, Monica
    Nomdedeu, Meritxell
    Cervantes, Francisco
    ONCOLOGY LETTERS, 2019, 17 (06) : 5705 - 5710